Christopher G. Tucker
Pediatrics | Internal Medicine
3305 Central Park Village Drive
Suite 200
Eagan, MN 55121
Suite 200
Eagan, MN 55121
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes.
Journal: Immunity
Published: November 02, 2023
Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses.
Journal: Scientific reports
Published: May 20, 2021
The Role of Programmed Death-1 in Type 1 Diabetes.
Journal: Current diabetes reports
Published: March 24, 2021
Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 17, 2020
Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression.
Journal: Nature immunology
Published: September 26, 2019
Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 20, 2018
Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
Journal: Scientific reports
Published: January 31, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026